Ireland· IE-PA-PA1077/023/002
Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV)
A hepatitis b, gereinigtes antigen product containing hepatitis b surface antigen, recominant, registered in Ireland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hepatitis b, gereinigtes antigen is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC01 (hepatitis b, gereinigtes antigen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Hepatitis b, gereinigtes antigen · ATC J07BC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Hepatitis b surface antigen, recominant
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- J07BC01
- ATC class
- Hepatitis B, gereinigtes Antigen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1077/023/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
255 interactions on record for hepatitis b, gereinigtes antigen.
Graded by severity as the source publishes them — 255 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hepatitis b, gereinigtes antigen · interactions on record
255 records
- 255 moderate
Most severe, free to view
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- PrednisoneA07EA03moderate
- BetamethasoneA07EA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J07BC01
Hepatitis b, gereinigtes antigen, as other registers publish it.
- PolandEngerix BGlaxoSmithKline Biologicals S.A.
- PolandEngerix BGlaxoSmithKline Biologicals S.A.
- IcelandEngerix BGlaxoSmithKline Pharma A/S
- SwitzerlandEngerix B 10
- SwitzerlandEngerix B 20
- BelgiumEngerix B 20 µg/1 mlGlaxoSmithKline Biologicals
- BelgiumEngerix B 20 µg/1 mlGlaxoSmithKline Biologicals
- BelgiumEngerix B Junior 10 µg/0.5 mlGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df97ef9f-b802-40dd-9943-c29178ed8c7c GET /v1/drugs/df97ef9f-b802-40dd-9943-c29178ed8c7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection in pre-filled syringe",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BC",
"J07BC01"
],
"strength": null,
"pa_number": "PA1077/023/002",
"substances": [
"Hepatitis b surface antigen, recominant"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "26/06/1998",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about hepatitis b, gereinigtes antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.